Credo Stock Slides 15% in 3 Months Despite Triple-Digit Growth; Sell-Side Sees 80% Upside

What happened

Credo Technology reported fiscal Q1 2027 revenue of $479 million, up 115% year over year, but GAAP gross margin slipped to 64.5% and customer concentration remained extreme, with top two customers at 71% of revenue. The stock has since declined roughly 15% over three months, prompting two Wall Street firms to argue the selloff created a compelling buying opportunity with up to 80% upside to their price targets. However, the fundamental thesis remains unchanged: optical revenue must ramp in 2H FY27 to diversify away from AEC dependence and justify current valuations. Credo still trades at over 60x earnings and 67x EV/EBITDA, leaving little margin for execution error. The market appears split between sell-side optimism and cautious investors awaiting proof of optical commercialization.

Implication

The sell-side's 80% upside view is not supported by our analysis until Credo shows concrete optical revenue inflection and gross margin stability. The next earnings report will be critical because it must confirm the $525-535 million revenue guide and non-GAAP gross margin of 67-69%; a miss could trigger further downside. We maintain our WAIT rating with attractive entry at $160 and trim above $220, as the current price of $187.80 offers balanced risk-reward at best. The extreme customer concentration and lack of long-term contracts mean one program change could dent results quickly. Investors should monitor January 2027 filings for disclosed optical production ramps or named customer wins before adding to positions.

Thesis delta

No change to our WAIT thesis. The article's bullish sell-side view does not alter our fundamental concerns about optical ramp timing, margin compression, and customer concentration. Our conviction remains moderate, and we would require evidence of optical commercialization before upgrading.